Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
- Written by PR Newswire Asia - Daily Bulletin Au RSS
Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA.
CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, is supporting a world-first clinical trial evaluating...





